Cargando…
Patients with low muscle mass have characteristic microbiome with low potential for amino acid synthesis in chronic liver disease
Sarcopenia is thought to be related to the microbiome, but not enough reports in chronic liver disease (CLD) patients. In addition to the differences in microbiome, the role of the microbiome in the gut is also important to be clarified because it has recently been shown that the microbiome may prod...
Autores principales: | Yamamoto, Kenta, Ishizu, Yoji, Honda, Takashi, Ito, Takanori, Imai, Norihiro, Nakamura, Masanao, Kawashima, Hiroki, Kitaura, Yasuyuki, Ishigami, Masatoshi, Fujishiro, Mitsuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901651/ https://www.ncbi.nlm.nih.gov/pubmed/35256716 http://dx.doi.org/10.1038/s41598-022-07810-3 |
Ejemplares similares
-
Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma
por: Inukai, Yosuke, et al.
Publicado: (2023) -
Changes in the gut microbiota after hepatitis C virus eradication
por: Honda, Takashi, et al.
Publicado: (2021) -
Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma
por: Mizuno, Kazuyuki, et al.
Publicado: (2023) -
The albumin–bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC
por: Ito, Takanori, et al.
Publicado: (2020) -
Proteomic Analysis Reveals Changes in Tight Junctions in the Small Intestinal Epithelium of Mice Fed a High-Fat Diet
por: Muto, Hisanori, et al.
Publicado: (2023)